These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1532139

  • 21. Electrolytic reduction of nitroheterocyclic drugs leads to biologically important damage in DNA.
    Lafleur MV, Zahoor A, Knight RC, Pluijmackers-Westmijze EJ, Loman H, Edwards DI.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Dec; 48(6):917-25. PubMed ID: 2933350
    [Abstract] [Full Text] [Related]

  • 22. Photosensitive interaction of RSU 1069 with DNA.
    Edwards DI, Knox RJ, Skolimowski IM, Zahoor A, Knight RC.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1319-22. PubMed ID: 6547937
    [Abstract] [Full Text] [Related]

  • 23. Contrasting effects of cytochrome C on the radiosensitivity of single-stranded phi X174 DNA in the presence of misonidazole or phenol under anoxia.
    Lafleur MV, Pluijmackers-Westmijze EJ, Loman H.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1195-7. PubMed ID: 6088446
    [Abstract] [Full Text] [Related]

  • 24. Induction of DNA strand breaks by RSU-1069, a nitroimidazole-aziridine radiosensitizer. Role of binding of both unreduced and radiation-reduced forms to DNA, in vitro.
    Silver AR, O'Neill P, Jenkins TC.
    Biochem Pharmacol; 1985 Oct 01; 34(19):3537-42. PubMed ID: 3902026
    [Abstract] [Full Text] [Related]

  • 25. Formation of different reaction products with single- and double-stranded DNA by the ortho-quinone and the semi-quinone free radical of etoposide (VP-16-213).
    Mans DR, Lafleur MV, Westmijze EJ, van Maanen JM, van Schaik MA, Lankelma J, Retèl J.
    Biochem Pharmacol; 1991 Nov 06; 42(11):2131-9. PubMed ID: 1958231
    [Abstract] [Full Text] [Related]

  • 26. Repair of damage induced by SR 4233.
    Edwards DI, Virk NS.
    Int J Radiat Oncol Biol Phys; 1992 Nov 06; 22(4):677-9. PubMed ID: 1531975
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers.
    Hei TK, Geard CR, Osmak RS, Hall EJ.
    Int J Radiat Oncol Biol Phys; 1985 Sep 06; 11(9):1653-8. PubMed ID: 3839777
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Studies with bifunctional bioreductive drugs. I. In vitro oncogenic transforming potential.
    Hei TK, He ZY, Piao CQ, Hall EJ.
    Radiat Res; 1990 Oct 06; 124(1 Suppl):S44-9. PubMed ID: 2236509
    [Abstract] [Full Text] [Related]

  • 35. RSU 1069, a nitroimidazole containing an aziridine group. Bioreduction greatly increases cytotoxicity under hypoxic conditions.
    Stratford IJ, O'Neill P, Sheldon PW, Silver AR, Walling JM, Adams GE.
    Biochem Pharmacol; 1986 Jan 01; 35(1):105-9. PubMed ID: 3753579
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Adduct formation is involved in radiosensitization, mediated by cytochrome c, of phi X174 DNA by misonidazole.
    Lafleur MV, Plijmackers-Westmijze EJ, Loman AC, Loman H.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Apr 01; 47(4):379-82. PubMed ID: 2985519
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.